FactoryTalk PharmaSuite MES forms more consistent high-quali

A pharmaceutical contract development and manufacturing organization (CDMO) faced growing pressure to deliver consistent product quality across a complex, multi-client value chain — a challenge amplified by the regulatory scrutiny inherent to pharmaceutical manufacturing. Relying on manual, paper-based processes for critical operations such as weighing and dispensing created unacceptable variability and compliance risk. Two-operator verification requirements for key procedures added labor overhead and slowed throughput. Without a unified digital foundation, data capture was fragmented, traceability was difficult to enforce, and the organization lacked the operational visibility needed to sustain quality standards at scale. The status quo threatened both regulatory standing and the organization's ability to grow its contract manufacturing business.

Rockwell Automation implemented FactoryTalk PharmaSuite, a manufacturing execution system (MES) purpose-built for life sciences environments and designed to meet stringent pharmaceutical regulatory requirements including 21 CFR Part 11 electronic records compliance. The deployment centered on digitizing core manufacturing workflows — particularly weigh-and-dispense operations — replacing manual recording with software-driven, automated data capture. FactoryTalk PharmaSuite was integrated into the facility's existing production environment to orchestrate and enforce electronic batch records, procedure workflows, and real-time data routing. This architecture eliminated manual transcription steps, enforced process controls at the point of execution, and created a consistent, auditable data trail across all production activities, forming the digital backbone required for the CDMO's broader transformation strategy.

The FactoryTalk PharmaSuite deployment delivered meaningful operational and quality improvements across the manufacturing floor. Weigh, dispense, and recording operations shifted fully to software control, eliminating paper-based documentation and the error risk associated with manual data entry. All production data is now handled and distributed automatically, giving quality and operations teams real-time visibility without manual aggregation.

• Staffing efficiency: Procedures previously requiring two-operator verification now run with a single operator, directly reducing labor overhead on regulated workflows.
• Data integrity: Automated capture closes the loop on traceability, supporting faster batch release and audit readiness.
• Consistency: Standardized electronic workflows reduce process variation across batches and production runs.

• Pharmaceutical CDMOs should prioritize MES platforms with native life sciences compliance features (e.g., electronic batch records, 21 CFR Part 11 support) to avoid costly custom development.
• Digitizing weigh-and-dispense operations is a high-ROI entry point: it reduces operator error, enforces procedural controls, and directly supports batch release timelines.
• Eliminating two-operator verification requirements through software-enforced controls can meaningfully reduce labor costs without compromising quality oversight.
• A purpose-built MES creates the data infrastructure needed for future initiatives — analytics, continuous improvement, and regulatory submissions all depend on clean, structured production records.